OBJECTIVE -To test the hypothesis that selected abnormalities cluster in type 2 diabetic families. Offspring of patients with type 2 diabetes have a 40-60% chance of developing type 2 diabetes and an increased frequency of impaired glucose tolerance (IGT) or unknown diabetes. These offspring also show metabolic abnormalities of type 2 diabetes, such as insulin resistance, high insulin and pro-insulin, low HDL cholesterol levels, arterial hypertension, and microalbuminuria.
O besity and distribution of body fat (1), impaired glucose tolerance (IGT), family history of type 2 diabetes (2,3), and lifestyle (4) represent risk factors for type 2 diabetes. Patients with clinically manifest type 2 diabetes, i.e., with hyperglycemia, show insulin resistance and reduced insulin release (5); hyperglycemia impairs both insulin action (6) and insulin release (7) , and this result makes it hard to understand which condition precedes the other in the pathogenesis of type 2 diabetes.
The offspring of type 2 diabetic patients appear to be a good group to study to learn about these abnormalities in the absence of the confounding effects of hyperglycemia; in fact, they have a 30-40% chance of developing type 2 diabetes (3) and frequently show abnormal glucose tolerance and several metabolic abnormalities of the full blown disease (8) (9) (10) (11) (12) (13) (14) (15) . These abnormalities include low insulin release (16) (17) (18) or insulin resistance (9, (19) (20) (21) (22) (23) (24) (25) , and insulin resistance is a risk factor for the development of type 2 diabetes (10, (26) (27) (28) . In addition, these offspring show high proinsulin levels (14) , arterial hypertension (9) , microalbuminuria (29) (30) (31) , high triglycerides (9) , low HDL cholesterol levels (12) , a raised BMI (12, 14) , and a high waist-tohip ratio (WHR) (12, 14) more commonly than control subjects chosen from the general population.
The concept of familial clustering is that if a proband shows an abnormality, the same abnormality will be more common among his or her offspring/siblings than among offspring/siblings of a proband without that abnormality. A few studies have indicated familial clustering of insulin resistance and microalbuminuria in the offspring of type 2 diabetic patients (15, 29, 32) , but nothing is known about the possible familial clustering of other abnormalities, and many of the studies on familial clustering included no control subjects (15, 29, 31, 32) .
Two criticisms can be made about studies performed so far. The first criticism is that studies on offspring have the inevitable limit of the age of the subjects, especially when they are studied before the age of 40 years. An alternative approach might be the study of siblings. They have an older age, and this makes one more confident that if the subject is not diabetic when evaluated, the chance of developing type 2 diabetes in the following years is reduced. The approach of siblings has been used to eval-Metabolic defects cluster in families with type 2 diabetes uate familial clustering of microalbuminuria (30, 31) and has yielded results similar to those of studies performed in offspring of type 2 diabetic patients (29) .
The second criticism is that in previous studies, control subjects were from the general population. It is known that members of the same family usually share lifestyle in terms of physical activity and diet, whereas control subjects chosen from the general population might have a different lifestyle.
The aim of this study was to evaluate the frequency and the possible familial clustering of a series of clinical and metabolic abnormalities in siblings of type 2 diabetic patients using control subjects from the same cohort, i.e., spouses of patients with type 2 diabetes without family history of diabetes.
RESEARCH DESIGN AND METHODS -
The study known as SPIDER (an Italian acronym that stands for Studio di Prevenzione dell' Insorgenza del Diabete ad Estensione Regionale, i.e., regional study of prevention of onset of type 2 diabetes) is an ongoing family study aimed at predicting and preventing type 2 diabetes in families with at least one patient affected by type 2 diabetes. The protocol of the study was approved by the Ethics Committee of Istituto San Raffaele, and advertisement of the aims and the nature of the study is on display in the outpatient clinics of the participating centers. All subjects provided informed consent.
Each family is made up of at least one type 2 diabetic patient (33) (the proband), his or her brothers and sisters (siblings), and the spouse of the proband without a family history of diabetes. Spouses have been chosen as control subjects of the same cohort and of similar age. When known type 2 diabetes affects more than one patient in one family, the patient with the longest duration of type 2 diabetes is considered the proband, and the remaining patients are considered together with siblings. We considered only families in which onset of type 2 diabetes was above the age of 40 years and in which type 2 diabetic patients were treated only with diet and/or hypoglycemic agents.
All subjects, i.e., probands, siblings, and spouses, were evaluated for BMI (in kg/m 2 ), WHR, and arterial blood pressure. All subjects filled out a questionnaire about physical activity (34) and a 3-day dietary recall (35) . A blood sample was drawn at fasting for evaluation of metabolic and endocrine variables including blood glucose, serum insulin, pro-insulin, C-peptide, triglycerides, cholesterol, HDL cholesterol, creatinine levels, and plasma free fatty acids. A sample of urine was collected for determination of microalbuminuria (36) . Siblings and spouses underwent a 75-g oral glucose tolerance test (OGTT), with a second evaluation of blood glucose, insulin, pro-insulin, and C-peptide at 120 min. On the basis of the OGTT (33), siblings and spouses were classified as having normal glucose tolerance (NGT) (75 vs. 46, respectively), IGT (31 vs. 14, respectively), or diabetes (newly diagnosed type 2 diabetes) (24 vs. 0, respectively). Table 1 shows clinical and metabolic details of probands, siblings, and spouses.
Assays
Blood glucose levels were measured by a glucose-oxidase method (YSI, Yellow Springs, OH). Free fatty acids (FFAs) and triglycerides were assayed by an enzymatic technique on a Cobas Fara II Centrifugal Analyzer (Cobas Fara II; Roche, Basel, Switzerland) (37) . FFA and triglyceride intra-assay coefficients of variation (CVs) were 2.3 and 1.7%, and the interassay CVs were 3.0 and 3.4%, respectively. Total cholesterol and HDL cholesterol were assayed by enzymatic automated spectro-photometric methods with a Cobas Fara II (intra-assay CV 4.3%, interassay CV 8.8%). Insulin was assayed by a Microparticle Enzyme Immunoassay (MEIA, IMX; Abbott Laboratories, Abbott Park, IL) with a monoclonal antibody without cross-reactivity with human pro-insulin (sensitivity 6.0 pmol/l; intra-assay CV 3.0%, interassay CV 5.0%). C-peptide was assayed by a commercial radioimmunoassay kit (DPC; Euro/DPC, Llanberis, U.K.) (sensitivity 0.005 ng/ml; intra-assay CV 3.0%, interassay CV 5.0%). Pro-insulin was assayed using a commercial kit without cross-reactivity with human insulin (Total Proinsulin; DAKO Diagnostics, Ely, U.K.) (sensitivity 2.0 pmol/l, intra-assay CV 7.0%, interassay CV 10.0%).
Calculations and statistical analysis
The homeostasis model assessment (HOMA) index (38) As expected, probands with microalbuminuria had a longer duration of diabetes; in addition, probands with a high BMI differed from probands with a low BMI for triglycerides, insulin, pro-insulin, C-peptide, and HOMA (not shown). Table 3 indicates that microalbuminuria, low HDL cholesterol and high proinsulin and insulin levels, and insulin resistance were more common in siblings than in spouses. In contrast, high triglycerides, high BMI, and a high WHR were equally distributed in probands, siblings, and spouses. In addition, familial clustering of 5 abnormalities occurred (method 1, microalbuminuria, arterial hypertension, pro-insulin and HDL cholesterol levels, and insulin resistance). Familial clustering of arterial hypertension, HDL cholesterol, and pro-insulin levels remained after exclusion of subjects with high BMI and, with the exception of pro-insulin, after further restriction of analysis to probands and to NGT siblings. Values exceeding these limits were considered abnormal. *Variables log-transformed before computing. Subjects with diastolic blood pressure Ͼ90 mmHg and/or with systolic blood pressure Ͼ140 mmHg or under treatment with hypotensive drugs were considered hypertensive; microalbuminuria was considered as absent/present. Of the families, 51 contributed 2 subjects each (proband and sibling), 20 contributed 3 subjects each, and 10, 2, 2, and 1 contributed 4, 5, 6, and 7 subjects each, respectively. When evaluated by the intraclass correlation coefficients (method 2), only systolic and diastolic blood pressure, HDL cholesterol, pro-insulin, and HOMA showed familial clustering (Table 4) ; clustering of insulin resistance (HOMA) disappeared when subjects with abnormal BMI were excluded from calculations, whereas the other variables maintained a familial clustering when subjects with abnormal BMI were excluded and when only probands and NGT siblings were considered.
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CONCLUSIONS -In agreement with previous studies comparing the offspring of patients with type 2 diabetes and control subjects from the general population (9, 12, 14, (16) (17) (18) (19) (20) (21) (22) , we found that low HDL cholesterol, high pro-insulin and insulin levels, and insulin resistance are more frequent among siblings of patients with type 2 diabetes than among adequate control subjects from the same cohort.
In this study, we used 2 different methods to evaluate familial clustering of selected abnormalities in families of probands with type 2 diabetes; the 2 methods yielded substantially identical results; the only difference was for pro-insulin, which showed familial clustering with method 2, not with method 1, when analysis was restricted to probands and NGT siblings. This difference is probably because method 2 evaluates continuous variables, whereas method 1 uses predefined cutoffs. We found that low HDL cholesterol and pro-insulin levels, systolic and diastolic blood pressure, and insulin resistance cluster in families of probands with type 2 diabetes; these results were obtained with both methods. In contrast, familial clustering of microalbuminuria was detected only with the first method of analysis, not with the second. The failure to confirm familial clustering of microalbuminuria is of note. In previous studies, in which only the presence/absence of microalbuminuria was taken into consideration, clustering was observed (29) (30) (31) . In this study, the clustering disappeared when subjects with high BMI were excluded, suggesting that the presence/absence of microalbuminuria is linked, among other things, to BMI. Indeed, even in previous studies, familial clustering of microalbuminuria was significantly correlated to BMI (31) . With the evaluation of intraclass correlation coefficients, this familial clustering disappeared, suggesting that microalbuminuria is not inherited directly but probably through the intervention of overweight, even though we cannot dismiss the possibility that differences between this and previous studies (29-31) might be due to a different method or to a different threshold for detection of microalbuminuria.
Also, the familial clustering of insulin resistance disappeared after exclusion of subjects with high BMI, suggesting that insulin resistance is linked, among other things, to excessive body weight; as a matter of fact, BMI was not taken into account in a previous study on clustering of insulin resistance in offspring (32) , and in the study by Vauhkonen et al. (15) , the similarity of offspring with probands was highly dependent on concordance of BMI. These data favor the hypothesis that this clustering is associated with body weight and is not really indicative of a specific genetic susceptibility to insulin resistance; however, a family history of type 2 diabetes increases the likelihood of developing obesity in adult life (40) , suggesting that insulin resistance, through a sustained low-grade hyperinsulinemia, can lead to increased BMI.
In contrast, HDL cholesterol and proinsulin levels and systolic and diastolic blood pressure showed a familial clustering, even after exclusion of subjects with high BMI and after further restriction of analysis to probands and NGT siblings. These data can be interpreted as markers of the earliest abnormalities in siblings; arterial hypertension and low HDL cholesterol are present when glucose tolerance is normal, whereas insulin resistance develops in the presence of IGT (16) . The meaning of these clusterings is at present unknown; however, the fact that some abnormalities are more frequent in certain families than in others is evident. Whether this finding also represents a real genetic susceptibility to a given abnormality is a matter for future studies.
A few considerations can be made. For instance, arterial hypertension is quite frequent in type 2 diabetes, found in 39% of patients at onset (41) , suggesting that it can exist before onset of type 2 diabetes. Raised levels of pro-insulin (14) and split proinsulin molecules (42) Metabolic defects cluster in families with type 2 diabetes abnormal lipoprotein lipase-to-hepatic lipase ratio in siblings of type 2 diabetic patients. In our study, families in which type 2 diabetes onset was before the age of 40 years were not considered; therefore, MODY subjects were likely to be excluded. In addition, it is unlikely that we considered families with familial hyperproinsulinemia because this condition is rare (44) , and the increase in pro-insulin levels observed in our study was marginal. These data only indicate that siblings of probands with a given abnormality are at a higher risk than siblings of probands without that abnormality to develop selected features of type 2 diabetes, whether these features are considered inherent to type 2 diabetes or complications of type 2 diabetes.
In conclusion, by studying type 2 diabetic probands, siblings, and spouses as adequate control subjects, we were able to show that low HDL cholesterol, insulin resistance, and high pro-insulin levels are frequent findings in siblings of type 2 diabetic patients. In addition, we found that systolic and diastolic blood pressure, low HDL cholesterol, and, to a lesser extent, high pro-insulin levels cluster in families. The meaning of these clusterings is still obscure, but it seems to indicate that siblings of type 2 diabetic patients are at high risk of developing selected features of type 2 diabetes.
